U.S. study calls into question tests that sequence tumor genes

CHICAGO (Reuters) – New cancer tests that sequence only a patient’s tumor and not normal tissue could result in a significant number of false positive results, potentially leading doctors to prescribe treatments that might not work, U.S. researchers said on Wednesday.

—> Read More